0000950170-23-052936.txt : 20231011
0000950170-23-052936.hdr.sgml : 20231011
20231011170038
ACCESSION NUMBER: 0000950170-23-052936
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20231011
DATE AS OF CHANGE: 20231011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elsbree David B
CENTRAL INDEX KEY: 0001292650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 231321245
MAIL ADDRESS:
STREET 1: C/O ACME PACKET, INC.
STREET 2: 100 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
ownership.xml
4
X0508
4
2023-09-15
0001492674
T2 Biosystems, Inc.
TTOO
0001292650
Elsbree David B
101 HARTWELL AVENUE
LEXINGTON
MA
02421
true
false
false
false
false
Common Stock
2023-09-15
4
M
false
2300
A
7824
D
Common Stock
200
I
By spouse
Restricted Stock Units
2023-09-15
4
M
false
2300
0
D
Common Stock
2300
0
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.
/s/ John Sprague, Attorney-in-Fact
2023-10-11